Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A microglia clonal inflammatory disorder in Alzheimer’s Disease

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE274037 | GEO | 2025/03/19

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

A microglia clonal inflammatory disorder in Alzheimer’s Disease II

Project description:Somatic genetic heterogeneity resulting from post-zygotic DNA mutations is widespread in human tissues and can cause diseases, however few studies have investigated its role in neurodegenerative processes such as Alzheimer’s Disease (AD). Here we report the selective enrichment of microglia clones carrying pathogenic variants, that are not present in neuronal, glia/stromal cells, or blood, from patients with AD in comparison to age-matched controls. Notably, microglia-specific AD-associated variants preferentially target the MAPK pathway, including recurrent CBL ring-domain mutations. These variants activate ERK and drive a microglia transcriptional program characterized by a strong neuro-inflammatory response, both in vitro and in patients. Although the natural history of AD-associated microglial clones is difficult to establish in human, microglial expression of a MAPK pathway activating variant was previously shown to cause neurodegeneration in mice, suggesting that AD-associated neuroinflammatory microglial clones may contribute to the neurodegenerative process in patients.

2025-03-19 | GSE286627 | GEO

A microglia clonal inflammatory disorder in Alzheimer’s Disease [dataset 1]

2025-03-19 | GSE274035 | GEO

A microglia clonal inflammatory disorder in Alzheimer’s Disease [dataset 2]

2025-03-19 | GSE274036 | GEO

A microglia clonal inflammatory disorder in Alzheimer’s Disease

Project description:A microglia clonal inflammatory disorder in Alzheimer’s Disease

| PRJNA1144494 | ENA

Immune checkpoint TIM-3 regulates microglia and Alzheimer’s disease

Project description:This SuperSeries is composed of the SubSeries listed below.

2025-01-15 | GSE223424 | GEO

A microglia clonal inflammatory disorder in Alzheimer's Disease.

Project description:Somatic genetic heterogeneity resulting from post-zygotic DNA mutations is widespread in human tissues and can cause diseases, however few studies have investigated its role in neurodegenerative processes such as Alzheimer's Disease (AD). Here we report the selective enrichment of microglia clones carrying pathogenic variants, that are not present in neuronal, glia/stromal cells, or blood, from patients with AD in comparison to age-matched controls. Notably, microglia-specific AD-associated variants preferentially target the MAPK pathway, including recurrent CBL ring-domain mutations. These variants activate ERK and drive a microglia transcriptional program characterized by a strong neuro-inflammatory response, both in vitro and in patients. Although the natural history of AD-associated microglial clones is difficult to establish in human, microglial expression of a MAPK pathway activating variant was previously shown to cause neurodegeneration in mice, suggesting that AD-associated neuroinflammatory microglial clones may contribute to the neurodegenerative process in patients.

| S-EPMC10849735 | biostudies-literature

A microglia clonal inflammatory disorder in Alzheimer's disease.

Project description:Somatic genetic heterogeneity resulting from post-zygotic DNA mutations is widespread in human tissues and can cause diseases, however, few studies have investigated its role in neurodegenerative processes such as Alzheimer's disease (AD). Here, we report the selective enrichment of microglia clones carrying pathogenic variants, that are not present in neuronal, glia/stromal cells, or blood, from patients with AD in comparison to age-matched controls. Notably, microglia-specific AD-associated variants preferentially target the MAPK pathway, including recurrent CBL ring-domain mutations. These variants activate ERK and drive a microglia transcriptional program characterized by a strong neuro-inflammatory response, both in vitro and in patients. Although the natural history of AD-associated microglial clones is difficult to establish in humans, microglial expression of a MAPK pathway activating variant was previously shown to cause neurodegeneration in mice, suggesting that AD-associated neuroinflammatory microglial clones may contribute to the neurodegenerative process in patients.

| S-EPMC11908784 | biostudies-literature

A microglia clonal inflammatory disorder in Alzheimer’s Disease II

Project description:A microglia clonal inflammatory disorder in Alzheimer’s Disease II

| PRJNA1209966 | ENA

THE UBIQUITIN-SPECIFIC PROTEASE 18 CONTROLS MICROGLIA QUIESCENCE UNDER HOMEOSTATIC AND INFLAMMATORY CONDITIONS

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-04-20 | E-GEOD-61501 | biostudies-arrayexpress

Single cell RNA-seq identifies a unique microglia type associated with Alzheimer’s disease

Project description:This SuperSeries is composed of the SubSeries listed below.

2017-06-12 | GSE98971 | GEO